ArticleAnnals of medicine and surgery (2012)2025

FDA approval of Amivantamab-Vmjw in combination with carboplatin and pemetrexed for EGFR-mutated NSCLC: a new therapeutic milestone.

Ibrahim Nagmeldin Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.